Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification - Quiz - MDSpire

Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification

  • By

  • Lixiao Shi

  • Dixiao Zhong

  • Ruihong Tang

  • Duanfang Shao

  • Xiang Cheng

  • Zhaoxia Zhang

  • Rong Liu

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification

  • by Lixiao Shi, Dixiao Zhong, Ruihong Tang, Duanfang Shao, Xiang Cheng, Zhaoxia Zhang, Rong Liu

  • June 15, 2026

Related Content

Primary malignant peripheral nerve sheath tumor of the liver: a case report and literature review

Cerebrovascular thrombosis during pediatric ALL therapy: a case series highlighting temporal association with PEG-asparaginase exposure

Dynamic identity management in online health communities: How illness stage moderates the effects of anonymity — A longitudinal panel data analysis